Effectiveness and safety assessment of add-on therapy of perampanel for epilepsy patients
Phase 3
- Conditions
- epilepsy syndromes
- Registration Number
- JPRN-UMIN000026880
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pregnancy patient 2. Simple partial seizure patient 3. Psychiatric unstable patient 4. Liver dysfunction patient 5. Alcoholic patient 6. Surgically treated patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of seizure frequency. The number of seizure attack every 2 weeks will be monitored.
- Secondary Outcome Measures
Name Time Method A complete seizure reduction ratio, 50% reduction ratio, tolerability and EEG